Cardinal Health Stock News

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. (Tuesday Market Open) Equity index futures are pointing higher as investors hope to build on Mondays rebound. Monday was a wild day with the stock market living up to its roller coaster reputation. However, with Federal Reserve Chairman Jerome Powell meeting with the Senate today, investors could still be a bit skittish. Stocks sold off on the open, with the S&P 500 (SPX) dropping 1.85% in the first hour but rallied off intraday lows to trim much of its losses. The S&P 500 closed down just 0.14%. The Nasdaq Composite ((COMP:GIDS)) led the selloff, falling 2.5% in the first hour of trading and easily broke the 14,900 support level. The next level of support would be around October 2021 lows near 14,200. However, the bulls refused to concede the line and pushed back to allow the Nasdaq to close 0.05% higher on a crazy day of trading. After spiking up over 23, the VIX ( Cboe Market Volatility Index ) subsided back below 21 as stocks rallied off their mid-day lows and closed at 19.33.

Cardinal Health Inc (NYSE: CAH ) shares are trading lower after the company warned of additional inflationary effects and lower volumes from global supply chain constraints with lower-than-anticipated offset from pricing actions. As a result, the incremental impact will be nearly $150 million $175 Full story available on Benzinga.com

Cardinal Health, Inc. (CAH) Management Presents at 40th JPMorgan Annual Healthcare Conference (Transcript)

Cardinal Health (CAH) is trading ~6.6% lower in the pre-market after the company warned of additional inflationary effects and lower volumes from global supply chain constraints

Cardinal Health Inc (NYSE: CAH) shares are trading lower after the company warned of additional inflationary effects and lower volumes from global supply chain constraints with lower-than-anticipated

Cardinal Health CAH, +3.29% said Monday the impact of inflation and supply chain disruptions will reduce its fiscal 2022 medical segment unit profit by $150 million to $175 million. Cardinal Health no

BOSTON , Jan. 10, 2022 /PRNewswire/ -- Medically Home today announced a new, $110 million round of funding from strategic investors including Baxter International Inc., Global Medical Response (GMR) and Cardinal Health who will each have representation on the company''s Board. Cardinal Health, Mayo Clinic and Kaiser Permanente are providing additional capital on top of their previous investments, demonstrating confidence in the growing expansion of the model nationwide. Medically Home Announces a $110 Million Investment The Medically Home model unlocks patients'' homes as safe alternative sites to receive high and lower acuity care across the care continuum in the comfort and convenience of their homes. This capability is designed to increase health system capacity and resiliency, while meeting the needs and wants of patients, who often prefer to be cared for at home or in a homelike setting. More than 7,000 patients have been treated using the Medically Home platform and ecosystem, as delivered by health systems across the country and utilization is expanding rapidly.

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio. However, contraction in gross margin is a woe.

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio. However, contraction in gross margin is a woe.

NEW YORK , Jan. 4, 2022 /PRNewswire/ -- According to the research report " Flow Diversion Aneurysm Treatment Market by Product and Geography - Forecast and Analysis 2021-2025 ", the market will witness a YOY growth of 7.85% in 2021 at a CAGR of 8.26% during the forecast period. Furthermore, this report extensively covers market segmentation by product (FDS and intrasaccular flow disruption devices) and geography ( North America , Europe , Asia , and ROW). For more insights on YOY and CAGR, Read our FREE Sample Report Vendor Insights The flow diversion aneurysm treatment market is concentrated and the vendors are deploying various organic and inorganic growth strategies to compete in the market. Owing to an increase in the prevalence of aortic and brain aneurysms and an increased desire for less invasive therapies the need for flow diversion aneurysm treatments is expected to rise during the forecast period. Vendors are primarily focusing on North America and Europe for the launch of new products.

Profiles of the major key market players operating in the global medical nonwoven disposables market include: Berry Global Inc. (U.S.), Asahei Kasei Corporation (Japan), Paul Hartmann AG (Germany), Kimberley-Clark Corporation (U.S.), Cardinal Health, Inc. (U.S.), Unicharm Corporation (Japan), Advanced Fabrics (SAAF) (Saudi Arabia), and Others. Profiles of the major key market players operating in the global medical nonwoven disposables market include: Berry Global Inc. (U.S.), Asahei Kasei Corporation (Japan), Paul Hartmann AG (Germany), Kimberley-Clark Corporation (U.S.), Cardinal Health, Inc. (U.S.), Unicharm Corporation (Japan), Advanced Fabrics (SAAF) (Saudi Arabia), and Others.

Key Companies Covered in the Japan PPE Gloves Market Research Report Are Supermax Corporation Berhad, Cardinal Health, Inc., Semperit Group, ATG Intelligent Glove Solutions, Honeywell International Inc., DIA RUBBER CO., LTD., 3M Company, Top Glove Corporation Bhd, Ansell Ltd., KIMBERLEY-CLARK CORPORATION, SHOWA GROUP, TOWA Corporation, Hartalega Holdings Berhad., and other key market players. Key Companies Covered in the Japan PPE Gloves Market Research Report Are Supermax Corporation Berhad, Cardinal Health, Inc., Semperit Group, ATG Intelligent Glove Solutions, Honeywell International Inc., DIA RUBBER CO., LTD., 3M Company, Top Glove Corporation Bhd, Ansell Ltd., KIMBERLEY-CLARK CORPORATION, SHOWA GROUP, TOWA Corporation, Hartalega Holdings Berhad., and other key market players.

DUBLIN, Ohio, Jan. 3, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2022 on February 3 prior to the opening of trading on the N

We provide a summary of upcoming ex-dividend dates in a quick reference table.

It is hard to believe 2021 is all but over and 2022 is upon us. The Santa Claus rally has carried the S&P 500 back to new all-time highs and everything seems set up for a strong January.